Filter results
You can narrow down the results using the filters
Topics
Our work
Diseases
11632 results
-
2:58Government Provider Management System – Adding users in GPMS
This video shows you how to add users to the Government Provider Management System. -
1:17Government Provider Management System – Editing access roles in GPMS
This video shows you how to edit users in the Government Provider Management System. -
2:52Government Provider Management System – Logging into GPMS
This video shows you how to log in to the Government Provider Management System. -
2022–23 Flexible aged care places (Multi-Purpose Services) allocations round – Application guide
This document provides information about the Flexible aged care places (Multi-Purpose Services) allocations round process. -
2022–23 Flexible aged care places (Multi-Purpose Services) allocations round – Application – Part A: Applicant details
Part A of the application for the 2022–23 Flexible aged care places (Multi-Purpose Services) allocations round – Applicant details. -
2022–23 Flexible aged care places (Multi-Purpose Services) allocations round – Application – Part B: New service – residential
Part B of the application for the 2022–23 Flexible aged care places (Multi-Purpose Services) allocations round – New service – residential -
2022–23 Flexible aged care places (Multi-Purpose Services) allocations round – Application – Part C: Existing service
Part C of the application for the 2022–23 Flexible aged care places (Multi-Purpose Services) allocations round – Existing service. -
Certification Statement – COVID-19 booster Top Up campaign
This certification statement, signed by Secretary Brendan Murphy on 27 March 2023, certifies that the COVID-19 booster Top Up campaign campaign complies with relevant guidelines and policies. -
Certification Statement – Routine Childhood Immunisation campaign
This certification statement, signed by Secretary Brendan Murphy on 31 March 2023, certifies that the Routine Childhood Immunisation campaign complies with relevant guidelines and policies. -
Cosmetic surgery (Image 9)
Social media image to support cosmetic surgery public education. -
Cosmetic surgery (Image 8)
Social media image to support cosmetic surgery public education. -
Cosmetic surgery (Image 2)
Social media image to support cosmetic surgery public education. -
Cosmetic surgery (Image 1)
Social media image to support cosmetic surgery public education. -
Cosmetic surgery (Image 7)
Social media image to support cosmetic surgery public education. -
Cosmetic surgery (Image 6)
Social media image to support cosmetic surgery public education. -
Cosmetic surgery (Image 3)
Social media image to support cosmetic surgery public education. -
Consumer contribution to aged care services report
Read this report by Kantar Public to see their research into a consumer contribution to aged care services. -
24/7 registered nurse responsibility exemption application form
This form should be used by approved providers of eligible residential facilities to apply for an exemption from the 24/7 registered nurse responsibility. -
Privacy notice – 24/7 registered nurse responsibility – APP 5 Notice
This privacy notice explains why we collect information in applications for exemptions from the 24/7 registered nurse responsibility. -
One more way you keep them safe poster
This campaign poster encourages you to vaccinate your child. -
Childhood vaccinations consumer brochure – DL version
This brochure provides information about the recommended vaccines available free for children under the National Immunisation Program. -
Life Saving Drugs Program resources – Gaucher disease
A collection of resources for health professionals to help people with Gaucher disease (type 1) access the following drugs under the Life Saving Drugs Program: imiglucerase (Cerezyme®), velaglucerase (VPRIV®), taliglucerase (Elelyso®) and eliglustat (Cerdelga®). -
Life Saving Drugs Program resources – Infantile-onset lysosomal acid-lipase deficiency disease (LAL-D)
A collection of resources for health professionals to help people with infantile-onset lysosomal acid-lipase deficiency disease (LAL-D) access sebelipase alfa (Kanuma®) under the Life Saving Drugs Program. -
COVID-19 National Health Plan – prescriptions via telehealth – a guide for pharmacists
Electronic prescribing was fast-tracked as part of the National Health Plan for coronavirus (COVID-19). This guide for pharmacists outlines arrangements available that will help patients receive medicines via telehealth services. -
COVID-19 National Health Plan – prescriptions via telehealth – a guide for prescribers
Electronic prescribing has been fast-tracked as part of the National Health Plan for coronavirus (COVID-19). This guide for prescribers outlines the temporary arrangements available now that will help patients receive medicines via telehealth services.